CERTIFICATION OF ENROLLMENT
ENGROSSED SUBSTITUTE HOUSE BILL 2115
68TH LEGISLATURE
2024 REGULAR SESSION
Passed by the House March 4, 2024
  Yeas 61  Nays 36
Speaker of the House of Representatives
Passed by the Senate February 23, 2024
  Yeas 33  Nays 14
President of the Senate
CERTIFICATE
I, Bernard Dean, Chief Clerk of the House of Representatives of the State of Washington, do hereby certify that the attached is ENGROSSED SUBSTITUTE HOUSE BILL 2115 as passed by the House of Representatives and the Senate on the dates hereon set forth.
Chief Clerk
Chief Clerk
Approved
FILED
Secretary of State
State of Washington
ENGROSSED SUBSTITUTE HOUSE BILL 2115
AS AMENDED BY THE SENATE
Passed Legislature - 2024 Regular Session
State of Washington
68th Legislature
2024 Regular Session
ByHouse Health Care & Wellness (originally sponsored by Representatives Thai, Slatter, Senn, Chapman, Reed, Ramel, Macri, Gregerson, Doglio, Fosse, Riccelli, Wylie, and Reeves)
READ FIRST TIME 01/22/24.
AN ACT Relating to prescription labels for medications used for abortion; and amending RCW 69.41.050.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
Sec. 1. RCW 69.41.050 and 2003 c 53 s 325 are each amended to read as follows:
(1) To every box, bottle, jar, tube, or other container of a legend drug, which is dispensed by a practitioner authorized to prescribe legend drugs, there shall be affixed a label bearing the name of the prescriber, complete directions for use, the name of the drug either by the brand or generic name and strength per unit dose, name of patient and date: PROVIDED, That the practitioner may omit the name and dosage of the drug if he or she determines that his or her patient should not have this information and that, if the drug dispensed is a trial sample in its original package and which is labeled in accordance with federal law or regulation, there need be set forth additionally only the name of the issuing practitioner and the name of the patient.
(2)(a) Notwithstanding subsection (1) of this section, at a prescriber's request, the prescription label for abortion medications may include the prescribing and dispensing health care facility name instead of the name of the practitioner.
(b) For the purposes of this subsection, "abortion medications" means substances used in the course of medical treatment intended to induce the termination of a pregnancy including, but not limited to, mifepristone.
(3) A violation of this section is a misdemeanor.
--- END ---